Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

RSV causes cold-like symptoms and affects the breathing passages and lungs. Wastewater levels of RSV are "moderate" nationwide for the week ending Dec. 28, according to the CDC's wastewater ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs. According to the CDC, RSV symptoms make it difficult to distinguish it from the common ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs and acts a lot like a common cold or mild flu, according to the CDC. It tends to spread ...

The CDC also mentioned respiratory syncytial virus (RSV), which is a virus that causes cold-like symptoms but also impacts breathing passages and the lungs. RSV has been trending upwards since ...

RSV is a common respiratory virus that causes mild, cold-like symptoms in healthy adults. Like similar viruses, it infects the nose, throat and lungs, making it difficult to tell apart from other ...

In older adults, GSK's Arexvy and Pfizer's Abrysvo offer similar protection against RSV-associated "lower respiratory tract disease" (LRTD), meaning infections that affect the lungs. In the first ...